Pasar al contenido principal

ESTUDIO DEL MECANISMO DE TRANSREGENERACION ACTIVADO POR EL SISTEMA INMUNE A TRAVES DE LRH1: TERAPIA BASADA EN PROCESOS DE CICATRIZACION DE HERIDAS PARA TRATAR LA DIABETES T1

PID2021-123083NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD, M.P.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Roles of extracellular vesicles associated non-coding RNAs in Diabetes Mellitus

  • Gauthier, Benoit R.
  • Cobo-Vuilleumier, Nadia
  • López-Noriega, Livia
Extracellular vesicles (EVs), especially exosomes (50 to 150 nm), have been shown to play important roles in a wide range of physiological and pathological processes, including metabolic diseases such as Diabetes Mellitus (DM). In the last decade, several studies have demonstrated how EVs are involved in cell-to-cell communication. EVs are enriched in proteins, mRNAs and non-coding RNAs (miRNAs, long non-coding RNAs and circRNAS, among others) which are transferred to recipient cells and may have a profound impact in either their survival or functionality. Several studies have pointed out the contribution of exosomal miRNAs, such as miR-l42-3p and miR-26, in the development of Type 1 and Type 2 DM (T1DM and T2DM), respectively. In addition, some miRNA families such as miR-let7 and miR-29 found in exosomes have been associated with both types of diabetes, suggesting that they share common etiological features. The knowledge about the role of exosomal long non-coding RNAs in this group of diseases is more immature, but the exosomal lncRNA MALAT1 has been found to be elevated in the plasma of individuals with T2DM, while more than 169 lncRNAs were reported to be differentially expressed between healthy donors and people with T1DM. Here, we review the current knowledge about exosomal non-coding RNAs in DM and discuss their potential as novel biomarkers and possible therapeutic targets., The authors were/are funded by grants from Consejería de Salud, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010, December 2010 to BG, PI-0085-2013),; Consejería de Economía, Innovación y Ciencia, Junta de Andalucía (P10-CTS-6359 to BG); Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, cofounded by Fondos FEDER (PI10/00871, January 2011 and PI13/00593, January 2014 to BG); Ministerio de Economía y Competitividad, Plan Nacional(BFU2017-83588-P, January 2018 and PID2021-123083NB-I00, sept 2022 to BG); JuvenileDiabetes Research Foundation JDRF (17-2013-372, August 2013 and 2-SRA-2019-837-S-B, August2019 to BG); Special thanks to ALUSVI (Asociación Lucha y Sonríe por la Vida, Pilas), and the Fundacion DiabetesCERO for their unconditional financial support. LL-N is also funded by Procedimiento de selección de personal investigador Doctor con cargo a las ayudas concedidas mediante la Línea de Ayudas para Captación, Incorporación y Movilidad de Capital Humano de I+D+i (20804).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The PTGS2/COX2-PGE2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus

  • Martín-Vázquez, Eugenia
  • Cobo-Vuilleumier, Nadia
  • López-Noriega, Livia
  • Lorenzo, Petra Isabel
  • Gauthier, Benoit R.
Prostaglandins are lipid mediators involved in physiological processes, such as constriction or dilation of blood vessels, but also pathophysiological processes, which include inflammation, pain and fever. They are produced by almost all cell types in the organism by activation of Prostaglandin endoperoxide synthases/Cyclooxygenases. The inducible Prostaglandin Endoperoxide Synthase 2/Cyclooxygenase 2 (PTGS2/COX2) plays an important role in pathologies associated with inflammatory signaling. The main product derived from PTGS2/COX2 expression and activation is Prostaglandin E (PGE), which promotes a wide variety of tissue-specific effects, pending environmental inputs. One of the major sources of PGE are infiltrating inflammatory cells - the production of this molecule increases drastically in damaged tissues. Immune infiltration is a hallmark of type 1 diabetes mellitus, a multifactorial disease that leads to autoimmune-mediated pancreatic beta cell destruction. Controversial effects for the PTGS2/COX2-PGE signaling cascade in pancreatic islet cells subjected to diabetogenic conditions have been reported, allocating PGE as both, cause and consequence of inflammation. Herein, we review the main effects of this molecular pathway in a tissue-specific manner, with a special emphasis on beta cell mass protection/destruction and its potential role in the prevention or development of T1DM. We also discuss strategies to target this pathway for future therapies., The authors are supported by grants from the Consejería de Salud, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010 to B.R.G., PI-0085-2013 to P.I.L.), the Consejería de Economía, Innovación y Ciencia (P10.CTS.6359 to B.R.G and DOC_00652 to L.L.N.), the Ministerio de Ciencia E Innovación co-funded by Fondos FEDER (PI10/00871, PI13/00593 and BFU2017- 83588-P, PID2021-123083NB-I00 to B.R.G), Vencer el Cancer (B.R.G), DiabetesCero (B.R.G.) and the Juvenile Diabetes Research Foundation (17-2013-372, 2-SRA-2019-837-S-B, 3-SRA-2023-1307-S-B to B.R.G.). E.M.V. is recipient of a Fellowship from the Ministerio de Ciencia E Innovación co-funded by Fondos FEDER (PRE2018-084907).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancing human islet xenotransplant survival and function in diabetic immunocompetent mice through LRH-1/NR5A2 pharmacological activation

  • Cobo-Vuilleumier, Nadia
  • Lorenzo, Petra Isabel
  • Martín-Vázquez, Eugenia
  • López-Noriega, Livia
  • Nano, R.
  • Piemonti, Lorenzo
  • Martín, Franz
  • Gauthier, Benoit R.
The intricate etiology of type 1 diabetes mellitus (T1D), characterized by harmful interactions between the immune system and insulin-producing beta cells, has hindered the development of effective therapies including human islet transplantation, which requires strong immunosuppressants that impair beta cell survival and function. As such alternative immunomodulating therapies are required for successful transplantation. The discovery that pharmacological activation of the nuclear receptor LRH-1/NR5A2 can reverse hyperglycemia in mouse models of T1D by altering, and not suppressing the autoimmune attack, prompted us to investigate whether LRH-1/NR5A2 activation could improve human islet function/survival after xenotransplantation in immunocompetent mice. Human islets were transplanted under the kidney capsule of streptozotocin (STZ)-induced diabetic mice, and treatment with BL001 (LRH-1/NR5A2 agonist) or vehicle was administered one week post-transplant. Our study, encompassing 3 independent experiments with 3 different islet donors, revealed that mice treated for 8 weeks with BL001 exhibited lower blood glucose levels correlating with improved mouse survival rates as compared to vehicle-treated controls. Human C-peptide was detectable in BL001-treated mice at both 4 and 8 weeks indicating functional islet beta cells. Accordingly, in mice treated with BL001 for 8 weeks, the beta cell mass was preserved, while a significant decrease in alpha cells was observed compared to mice treated with BL001 for only 4 weeks. In contrast, vehicle-treated mice exhibited a reduction in insulin-expressing cells at 8 weeks compared to those at 4 weeks. These results suggest that BL001 significantly enhances the survival, engraftment, and functionality of human islets in a STZ-induced diabetic mouse model., The authors are supported by grants from the Consejería de Salud y Consumo, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010 and PI-0001-2020 to BRG), the Consejería de Economía, Innovación y Ciencia (P10.CTS.6359 to BRG), the Ministerio de Ciencia E Innovación (BFU2017-83588-P, PID2021-123083NB-I00 financed by MCIN/AEI/10.13039/501100011033 and by FEDER, UE to BRG), The DiabetesCERO Foundation (BRG), the Spanish Diabetes Society and the Juvenile Diabetes Research Foundation (17-2013-372, 2-SRA-2019-837-S-B, 3-SRA-2023-1307-S-B to BRG)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Roles for the long non-coding RNA Pax6os1/PAX6-AS1 in pancreatic beta cell function

  • López-Noriega, Livia
  • Callingham, Rebecca
  • Martínez-Sánchez, Aida
  • Nawaz, Sameena
  • Pizza, Grazia
  • Haberman, Nejc
  • Cvetesic, Nevena
  • Nguyen-Tu, Marie-Sophie
  • Lenhard, Boris
  • Marchetti, Piero
  • Piemonti, Lorenzo
  • Koning, Eelco de
  • Shapiro, A. M. James
  • Johnson, Paul R.
  • Leclerc, Isabelle
  • Hastoy, Benoit
  • Gauthier, Benoit R.
  • Pullen, Timothy J.
  • Rutter, Guy A.
Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of beta cell function. Here, we show that an lncRNA-transcribed antisense to Pax6, annotated as Pax6os1/PAX6-AS1, was upregulated by high glucose concentrations in human as well as murine beta cell lines and islets. Elevated expression was also observed in islets from mice on a high-fat diet and patients with type 2 diabetes. Silencing Pax6os1/PAX6-AS1 in MIN6 or EndoC-βH1 cells increased several beta cell signature genes' expression. Pax6os1/PAX6-AS1 was shown to bind to EIF3D, indicating a role in translation of specific mRNAs, as well as histones H3 and H4, suggesting a role in histone modifications. Important interspecies differences were found, with a stronger phenotype in humans. Only female Pax6os1 null mice fed a high-fat diet showed slightly enhanced glucose clearance. In contrast, silencing PAX6-AS1 in human islets enhanced glucose-stimulated insulin secretion and increased calcium dynamics, whereas overexpression of the lncRNA resulted in the opposite phenotype., G.A.R. was supported by Wellcome Trust Senior Investigator (WT098424AIA) and Investigator (WT212625/Z/18/Z) Awards, MRC Programme grant (MR/R022259/1), Diabetes UK (BDA/11/0004210, BDA/15/0005275, BDA 16/0005485), Imperial Confidence in Concept (ICiC) grants, an NIH-NIDDK project grant (R01DK135268), a CIHR-JDRF Team grant (CIHR-IRSC TDP-186358 and JDRF 4-SRA-2023-1182-S-N), CRCHUM start-up funds, and an Innovation Canada John R. Evans Leader Award (CFI 42649). G.A.R. and P.M. received funding from the European Union’s Horizon 2020 research and innovation programme via the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115881 (RHAPSODY). A.M.-S. was supported by an MRC New Investigator Research Grant (MR/P023223/1). B.H. was supported by RD Lawrence fellowship (BDA number:19/0005965). This project has received funding from the European Union’s Horizon 2020 research and innovation program via the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115881 (RHAPSODY) to G.A.R. and P.M. B.R.G. is supported by Ministerio de Ciencia e Innovación de España (PID2021-123083NB-I00 financed by MCIN/AEI/10.13039/501100011033 and by FEDER, UE) and the Juvenile Diabetes Research Foundation (3-SRA-2023-1307-S-B). L.L.N. is supported by the Consejería de Economía, Innovación y Ciencia (DOC_00652, FSE and Lema: Andalucía moves with Europe). The E.J.P. de K. lab is financially supported by the Dutch Diabetes Research Foundation, DON Foundation, Tjanka Foundation, Bontius Foundation, and RegMedXB. We thank the Oxford Biomedical Research Center (BRC), Diabetes Research and Wellness Foundation (DRWF), and Juvenile Diabetes Research Foundation (JDRF) for the provision of human islets. Human islets for research were also provided by the Alberta Diabetes Institute IsletCore at the University of Alberta in Edmonton (http://www.bcell.org/adi-isletcore.html) with the assistance of the Human Organ Procurement and Exchange (HOPE) program, Trillium Gift of Life Network (TGLN), and other Canadian organ procurement organizations. Islet isolation was approved by the Human Research Ethics Board at the University of Alberta (Pro00013094). All donors' families gave informed consent for the use of pancreatic tissue in research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

LRH-1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype

  • Cobo-Vuilleumier, Nadia
  • Rodríguez-Fernandez, Silvia
  • López-Noriega, Livia
  • Lorenzo, Petra I.
  • Franco, Jaime M.
  • Lachaud, Christian C.
  • Martín-Vázquez, Eugenia
  • Legido, Raquel Araujo
  • Dorronsoro, Akaitz
  • López-Férnandez-Sobrino, Raul
  • Fernández-Santos, Beatriz
  • Espejo Serrano, Carmen
  • Salas-Lloret, Daniel
  • van Overbeek, Nila
  • Ramos-Rodriguez, Mireia
  • Mateo-Rodríguez, Carmen
  • Hidalgo, Lucia
  • Marin-Canas, Sandra
  • Nano, Rita
  • Arroba, Ana I.
  • Campos Caro, Antonio
  • Vertegaal, Alfred C. O.
  • Martín-Montalvo, Alejandro
  • Martín, Franz
  • Aguilar-Diosdado, Manuel
  • Piemonti, Lorenzo
  • Pasquali, Lorenzo
  • González Prieto, Roman
  • García Sánchez, Maria Isabel
  • Eizirik, Decio L.
  • Martínez-Brocca, Maria Asuncion
  • Vives-Pi, Marta
  • Gauthier, Benoit R.
The complex aetiology of type 1 diabetes (T1D), characterised by a detrimental cross-talk between the immune system and insulin-producing beta cells, has hindered the development of effective disease-modifying therapies. The discovery that the pharmacological activation of LRH-1/NR5A2 can reverse hyperglycaemia in mouse models of T1D by attenuating the autoimmune attack coupled to beta cell survival/regeneration prompted us to investigate whether immune tolerisation could be translated to individuals with T1D by LRH-1/NR5A2 activation and improve islet survival., We thank Dr Maria José Quintero from the Cytometry Core Facility and the team from the Genomic Core Facility of CABIMER, as well as Pedro Antonio Soriano Fernandez and Noelia García Rodríguez for their excellent technical support. Special thanks to all donors and to the Biobank Node of the Hospital Virgen Macarena (Biobanco del Sistema Sanitario Público de Andalucía) which is part of the Spanish National biobanks Network (PT20/00069) supported by Instituto Carlos III and FEDER funds. We acknowledge the support of the Basic Experimentation in Diabetes study group of the Spanish Association of Diabetes as well as positive discussion through the Consolidated Research Group 2021 SGR 00002, AGAUR, Generalitat de Catalunya. We also acknowledge the use of DeepL write and ChatGTP for English editing purposes. The authors are supported by grants from the Consejería de Salud y Consumo, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0727-2010 and PI-0001-2020 to B. R. G), the Consejería de Economía, Innovación y Ciencia (P10.CTS.6359 to B. R. G and DOC_00652, FSE and Lema: Andalucía moves with Europe to L. L. N.), the Ministerio de Ciencia E Innovación (BFU2017-83588-P, PID2021-123083NB-I00 financed by MCIN/AEI/10.13039/501100011033 and by FEDER, UE to B. R. G.), the DiabetesCERO Foundation (B. R. G.), the Spanish Diabetes Society (B. R. G.) and the Juvenile Diabetes Research Foundation/Breakthrough TD1 (17-2013-372, 2-SRA-2019-837-S-B, 3-SRA-2023-1307-S-B to B. R. G; 3-SRA-2022-1201-S-B(1) to D. L. E.), the National Institutes of Health Human Islet Research Network Consortium on Beta Cell Death & Survival from Pancreatic Beta Cell Gene Networks to Therapy [HIRN-CBDS], (U01 DK127786 to D. L. E.) and the National Institutes of Health, NIDDK (RO1DK126444 and RO1DK133881-01 to D. L. E.). P. A. S. F. is contracted through an action funded by the EU- NextGenerationEU, and the Recovery, Transformation and Resilience Plan (SE/INV/0008/2022) granted to the Consejería de Empleo, Formación y Trabajo Autónomo of the Junta de Andalucía in the 2022 call of the Investigo Program, Mechanism for Recovery and Resilience. E. M. V. is the recipient of a post-doctoral fellowship from the Belgian FNRS., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of lipotoxic hepatocyte-derived extracellular vesicles in pancreas inflammation: essential role of macrophage TLR4 in beta cell functionality

  • Alén, Rosa
  • García-Martínez, Irma
  • Cobo-Vuilleumier, Nadia
  • Fernández-Millán, Elisa
  • Gallardo-Villanueva, Paula
  • Ferreira, Vítor
  • Izquierdo, Manuel
  • Moro, María Ángeles
  • Lizasoain, Ignacio
  • Nieto, Natalia
  • Gauthier, Benoit R.
  • Valverde, Ángela M.
[Aims/hypothesis]: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common feature of obesity and type 2 diabetes. Under lipotoxic stress, hepatocytes release small extracellular vesicles (sEVs) which act locally and contribute to MASLD progression, but their role in beta cell function and development of type 2 diabetes remains largely unexplored. We aimed to examine whether hepatocyte-derived sEVs (Hep-sEVs) under lipotoxic conditions impact on liver and pancreas inflammation and subsequent effects on beta cell function., [Methods]: Primary mouse hepatocytes and Huh7 human hepatocytes were treated with palmitic acid and Hep-sEVs were purified from the culture medium by differential ultracentrifugation. In vitro and in vivo approaches were used to decipher the role of Hep-sEVs in liver and pancreas inflammation and beta cell dysfunction in mouse and human pancreatic islets. The contribution of the Toll-like receptor 4 (TLR4) to Hep-sEV-mediated effects was investigated in pancreatic islets from myeloid-specific TLR4-deficient mice., [Results]: Lipotoxic Hep-sEVs targeted pancreatic islet macrophages and induced TLR4-mediated inflammation. The subsequent inflammatory response downregulated beta cell identity genes and impaired glucose-stimulated insulin secretion in both INS-1 beta cells (p<0.05) and isolated pancreatic islets from mice (p<0.01) and humans (p<0.05). Specific deletion of TLR4 in macrophages protected pancreatic islets against inflammation and the impairment of glucose-stimulated insulin secretion induced by lipotoxic Hep-sEVs. Chronic administration of lipotoxic Hep-sEVs in lean mice induced liver and pancreas inflammation through the recruitment of immune cells. This intervention induced hepatocyte injury and fibrotic damage together with detrimental immunometabolic systemic effects. Insulin resistance in hepatocytes (p<0.01) and a compensatory insulin secretion (p<0.001) that prevented glucose intolerance were also observed in mice treated with lipotoxic Hep-sEVs., [Conclusions/interpretation]: This study has provided evidence of liver and pancreas inflammation and beta cell dysfunction induced by lipotoxic Hep-sEVs. Our data also envision TLR4-mediated signalling in islet macrophages as a key mediator of the effects of lipotoxic Hep-sEVs on beta cell function., This work was supported by grants PID2021-122766OB-I00 (AMV), PID2022-140616OB-I00 (MAM), PID2020-116134RB-I00 (EF-M), PID2021-123083NB-I00 (BRG) and RD21/0006/0001 (ISCIII) (IL) funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by “ERDF A way of making Europe”, by “ERDF/EU”, by the “European Union” or by the “European Union NextGenerationEU/PRTR”, grant EFSD/Boehringer Ingelheim European Research Programme on 'Multi-System Challenges in Diabetes' from the European Foundation for the Study of Diabetes (AMV), P2022/BMD-7227 (Comunidad de Madrid, Spain) (AMV), Fundación Ramón Areces (Spain) (AMV), Horizon-EIC-Pathfinder-Challenge-2023, grant agreement number 101162517, European Union (AMV), Breakthrough T1D (formerly known as JDRF; 3-SRA-2023-1307-S-B to BRG), CIBERdem (ISCIII, Spain) (AMV and BRG), 1R01DK134461 from the National Institute of Diabetes and Digestive and Kidney Diseases (NN) and 1I01BX005093 from the Department of Veterans Affairs (Biomedical Laboratory Research and Development). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government (NN). AMV belongs to the Spanish National Research Council (CSIC)’s Cancer and Metabolism (COMETA) Hubs and Instituto de Investigación Sanitaria La Paz (IdiPaz) (Madrid, Spain). We also acknowledge the Spanish Ministry of Economy and Competitiveness (MINECO) for the postdoctoral contract IJCI-2015-24758 to IG-M and the Spanish Ministry of Education, Culture and Sport (MECD) for the FPU17/02786 grant to RA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human Omental Mesothelial Cells Exhibit a Corneal Endothelial-Like Cell Phenotype for Tissue Engineering of a Corneal Endothelium Biomimetic

  • Alió, Jorge L.
  • Gauthier, Benoit R.
  • Gómez Rosado, Juan C.
  • Alió Del Barrio, Jorge L.
  • Rodríguez, Alejandra E.
  • Díaz Corrales, Francisco J.
  • Capitán Morales, Luis C.
  • Soria, Bernat
  • Lachaud, Christian C.
Purpose: To evaluate whether cultured human omental mesothelial cells (OMC) exhibit phenotypic and functional similarities to human corneal endothelial cells (CEC) and whether they can adhere to the corneal stroma and form a biomimetic corneal endothelium when grown on a human anterior lens capsule (HALC). Methods: Human OMC were isolated from the greater omentum. Human B4G12 CEC were used as a reference for native and functional CEC phenotype whereas human mesenchymal stromal cells (MSC) served as a phenotypically distinct control group. OMC, CEC and MSC were compared using flow cytometry, immunofluorescence and qRT-PCR for lineage-specific markers, as well as through a transepithelial permeability assay. The adhesion capacity of OMC was also evaluated on both mouse corneal stroma and a decellularized HALC. Results: Several cell-surface markers commonly expressed at high levels in MSC (CD13, CD105, CD73 and CD44) were detected at markedly lower levels in OMC and CEC. OMC and CEC, but not MSC, also shared a similar expression profile of key structural markers (pan cytokeratin, ZO-1, β-catenin, N-cadherin, COL4A2, COL8A2) and functional corneal endothelium markers (AQP1, ATP1A1, SLC4A11, CLCN-3). In addition, OMC demonstrated transepithelial permeability values comparable to those of CEC monolayers supporting their barrier-forming capacity. Both CEC and OMC formed cobblestone-like monolayers on mouse corneal stroma and OMC seeded onto HALC generated a bioconstruct that reproduced the key morphological and ultra-structural features of native corneal endothelium. Conclusions: Overall, our findings show that cultured human OMC exhibit phenotypic and functional similarities to CEC. The ability of OMC to adhere to the corneal stroma and to generate a biomimetic corneal endothelium when combined with HALC highlights their potential use in corneal endothelial regeneration., Supported by the grant from the Consejería de Salud y Consumo, Fundación Pública Andaluza Progreso y Salud, Junta de Andalucía (PI-0007-2016 to C.C.L.) and Ministerio de Ciencia e Innovación (PID2021-123083NB-I00 to B.R.G.)., Peer reviewed